Kennedy Says FDA Reviewing Safety of Abortion Pill Mifepristone

Key Takeaways

  • The U.S. Food and Drug Administration is conducting a safety review of the abortion pill mifepristone

  • The review comes after conservative and anti-abortion groups raised concerns about the drug and access to it

  • The review may alter how the drug is prescribed, but an outright ban is unlikely

Originally published on healthday.com, part of the BLOX Digital Content Exchange.